Showing results (91-100 of 311) with videos related to
Sort By:
Pageof 32
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.Journal of Parkinson'S Disease|October 3, 2025
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathiesIlham Y Abdi, Indulekha P Sudhakaran, Simona S Ghanem, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2011
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCIIrene Litvan, Dag Aarsland, Charles H Adler, et al.Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.Journal of Neuroscience Research|October 28, 2009
Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseasesSandra Ebert, Miriam Goos, Lena Rollwagen, et al.Proteomics. Clinical Applications|December 8, 2010
CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fractionMirko Bibl, Piotr Lewczuk, Hermann Esselmann, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2017
Distinct metabolomic signature in cerebrospinal fluid in early parkinson's diseaseJean-Pierre Trezzi, Sara Galozzi, Christian Jaeger, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 7, 2011
Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob diseaseBrit Mollenhauer, Hermann Esselmann, Sigrun Roeber, et al.Plos One|November 30, 2018
Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker researchLukas M Schilde, Steffen Kösters, Simone Steinbach, et al.Proteomics|September 25, 2008
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob diseasePeter Brechlin, Olaf Jahn, Petra Steinacker, et al.Pageof 32